Filing Details

Accession Number:
0001348362-25-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-30 11:34:10
Reporting Period:
2025-07-29
Filing Date:
2025-07-30
Accepted Time:
2025-07-30 11:34:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348362 Lexaria Bioscience Corp. LEXX Pharmaceutical Preparations (2834) 202000871
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638727 Martin John Docherty 23 Mikelen Drive
Port Perry A6 L9L 1V1
President & Cso Yes Yes No No
Transaction Summary
Purchased: 5,376 shares Avg. Price: $0.93 Total Value: $4,988.93
Number of Shares After Transactions: 5,376 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2025-07-29 5,376 $0.93 5,376 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 54,075 Indirect Private Holding Company
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Stock Options $3.00 2021-04-26 2026-04-26 18,000 18,000 Direct
Common Shares Stock Options $3.00 2021-06-08 2026-06-08 18,334 36,334 Direct
Common Shares Stock Options $3.00 2021-09-01 2026-09-01 15,000 51,334 Direct
Common Shares Stock Options $2.91 2022-08-29 2027-08-29 30,000 81,334 Direct
Common Shares Stock Options $1.15 2023-10-26 2028-10-26 30,000 111,334 Direct
Common Shares Stock Options $2.36 2024-04-26 2029-04-26 49,500 160,834 Direct
Common Shares Stock Options $1.04 2025-05-15 2030-05-15 150,000 310,834 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-04-26 18,000 18,000 Direct
2026-06-08 18,334 36,334 Direct
2026-09-01 15,000 51,334 Direct
2027-08-29 30,000 81,334 Direct
2028-10-26 30,000 111,334 Direct
2029-04-26 49,500 160,834 Direct
2030-05-15 150,000 310,834 Direct